These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16091482)

  • 1. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.
    Straznicky NE; Lambert EA; Lambert GW; Masuo K; Esler MD; Nestel PJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):5998-6005. PubMed ID: 16091482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.
    Straznicky NE; Grima MT; Eikelis N; Nestel PJ; Dawood T; Schlaich MP; Chopra R; Masuo K; Esler MD; Sari CI; Lambert GW; Lambert EA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E503-8. PubMed ID: 21177786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects.
    Straznicky NE; Eikelis N; Nestel PJ; Dixon JB; Dawood T; Grima MT; Sari CI; Schlaich MP; Esler MD; Tilbrook AJ; Lambert GW; Lambert EA
    J Clin Endocrinol Metab; 2012 Feb; 97(2):605-13. PubMed ID: 22090279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss.
    Lambert EA; Rice T; Eikelis N; Straznicky NE; Lambert GW; Head GA; Hensman C; Schlaich MP; Dixon JB
    Am J Hypertens; 2014 Oct; 27(10):1308-15. PubMed ID: 24717419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.
    Grassi G; Seravalle G; Colombo M; Bolla G; Cattaneo BM; Cavagnini F; Mancia G
    Circulation; 1998 May; 97(20):2037-42. PubMed ID: 9610534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients.
    Seravalle G; Colombo M; Perego P; Giardini V; Volpe M; Dell'Oro R; Mancia G; Grassi G
    Hypertension; 2014 Aug; 64(2):431-7. PubMed ID: 24866140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects.
    Straznicky NE; Lambert EA; Nestel PJ; McGrane MT; Dawood T; Schlaich MP; Masuo K; Eikelis N; de Courten B; Mariani JA; Esler MD; Socratous F; Chopra R; Sari CI; Paul E; Lambert GW
    Diabetes; 2010 Jan; 59(1):71-9. PubMed ID: 19833893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic system activity in obesity and metabolic syndrome.
    Tentolouris N; Liatis S; Katsilambros N
    Ann N Y Acad Sci; 2006 Nov; 1083():129-52. PubMed ID: 17148737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Mariani JA; Kobayashi D; Hering D; Dixon JB; Lambert GW
    Front Physiol; 2016; 7():516. PubMed ID: 27857694
    [No Abstract]   [Full Text] [Related]  

  • 15. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
    Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
    Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.
    Grassi G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Seravalle G; Paleari F; Gamba PL; Mancia G
    Diabetologia; 2005 Jul; 48(7):1359-65. PubMed ID: 15933859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men.
    Schwartz RS; Jaeger LF; Veith RC; Lakshminarayan S
    Int J Obes; 1990 Jan; 14(1):1-11. PubMed ID: 2179146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.
    Straznicky NE; Lambert GW; McGrane MT; Masuo K; Dawood T; Nestel PJ; Eikelis N; Schlaich MP; Esler MD; Socratous F; Chopra R; Lambert EA
    Diabetes; 2009 May; 58(5):1126-32. PubMed ID: 19188428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.